Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1978 Aug;8(2):171–176. doi: 10.1128/jcm.8.2.171-176.1978

Immunoglobulin-specific radioimmunoprecipitation assays for quantitation of nasal secretory antibodies to hemagglutinin of type A influenza viruses.

J A Kasel, H R Six, C J Oborn, G R Dreesman
PMCID: PMC275182  PMID: 100506

Abstract

Radioimmunoprecipitation (RIP) assays were developed to selectively quantitate class-specific antibodies to purified hemagglutinins (HA) of type A influenza virus in nasal secretions. Rabbit anti-human secretory piece of immunoglobulin A (IgA) and rabbit anti-human IgG were used as second antibodies. A third antibody, goat anti-rabbit IgG, was incorporated into the system to separate immune complexes formed between iodinated HA, nasal wash test specimen, and second antibody. The utilization of this reagent avoided the need for large quantities of IgA and IgG antibody-negative carrier secretions. Nasal was specimens obtained from 14 adults immunized with an inactivated type A influenza virus vaccine were evaluated by RIP and viral neutralization assays. Significant homologous postvaccination secretory IgA and IgG antibody levels were demonstrable in 13 (93%) of individuals by RIP, whereas only 5 (36%) exhibited rises by viral neutralization tests. Moreover, the geometric mean IgA and IgG antibody levels were at least 20- and 37-fold greater than the neutralizing antibody titer. The pattern of heterologous immunoglobulin-specific antibody responses tended to be similar to those observed with the homologous HA subunit.

Full text

PDF
171

Images in this article

173Image
on p.173

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alford R. H., Rossen R. D., Butler W. T., Kasel J. A. Neutralizing and hemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus. J Immunol. 1967 Apr;98(4):724–731. [PubMed] [Google Scholar]
  2. BELLANTI J. A., ARTENSTEIN M. S., BUESCHER E. L. CHARACTERIZATION OF VIRUS NEUTRALIZING ANTIBODIES IN HUMAN SERUM AND NASAL SECRETIONS. J Immunol. 1965 Mar;94:344–351. [PubMed] [Google Scholar]
  3. Brandtzaeg P., Fjellanger I., Gjeruldsen S. T. Human secretory immunoglobulins. I. Salivary secretions from individuals with normal or low levels of serum immunoglobulins. Scand J Haematol Suppl. 1970;12:3–83. [PubMed] [Google Scholar]
  4. Couch R. B., Douglas R. G., Jr, Fedson D. S., Kasel J. A. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. J Infect Dis. 1971 Nov;124(5):473–480. doi: 10.1093/infdis/124.5.473. [DOI] [PubMed] [Google Scholar]
  5. Eckert E. A. Properties of an antigenic glycoprotein isolated from influenza virus hemagglutinin. J Virol. 1973 Feb;11(2):183–192. doi: 10.1128/jvi.11.2.183-192.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fedson D. S., Fulk R. V., Huber M. A., Reisberg M. A., Kasel J. A. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine. J Immunol. 1971 Sep;107(3):730–737. [PubMed] [Google Scholar]
  7. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hierholzer J. C., Suggs M. T., Hall E. C. Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation. Appl Microbiol. 1969 Nov;18(5):824–833. doi: 10.1128/am.18.5.824-833.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kasel J. A., Couch R. B., Six H. R., Knight V. Antigenicity of licensed whole virion and subvirion influenza vaccines in "high risk" persons. Proc Soc Exp Biol Med. 1976 Apr;151(4):742–747. doi: 10.3181/00379727-151-39298. [DOI] [PubMed] [Google Scholar]
  10. Kasel J. A., Hume E. B., Fulk R. V., Togo Y., Huber M., Hornick R. B. Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine. J Immunol. 1969 Mar;102(3):555–562. [PubMed] [Google Scholar]
  11. LAVER W. G. STRUCTURAL STUDIES ON THE PROTEIN SUBUNITS FROM THREE STRAINS OF INFLUENZA VIRUS. J Mol Biol. 1964 Jul;9:109–124. doi: 10.1016/s0022-2836(64)80094-2. [DOI] [PubMed] [Google Scholar]
  12. Laver W. G., Downie J. C., Webster R. G. Studies on antigenic variation in influenza virus. Evidence for multiple antigenic determinants on the hemagglutinin subunits of A-Hong Kong-68 (H3 N2) virus and the A-England-72 strains. Virology. 1974 May;59(1):230–244. doi: 10.1016/0042-6822(74)90218-9. [DOI] [PubMed] [Google Scholar]
  13. MARTIN R. G., AMES B. N. A method for determining the sedimentation behavior of enzymes: application to protein mixtures. J Biol Chem. 1961 May;236:1372–1379. [PubMed] [Google Scholar]
  14. OUCHTERLONY O. Diffusion-in-gel methods for immunological analysis. Prog Allergy. 1958;5:1–78. [PubMed] [Google Scholar]
  15. Rossen R. D., Butler W. T., Vannier W. E., Douglas R. G., Jr, Steinberg A. G. The sedimentation and antigenic properties of proteins in nasal and other external secretions. J Immunol. 1966 Dec;97(6):925–938. [PubMed] [Google Scholar]
  16. Rossen R. D., Schade A. L., Butler W. T., Kasel J. A. The proteins in nasal secretion: a longitudinal study of the gammaA-globulin, gammaG-globulin, albumin, siderophilin, and total protein concentrations in nasal washings from adult male volunteers. J Clin Invest. 1966 May;45(5):768–776. doi: 10.1172/JCI105391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. SHELOKOV A., VOGEL J. E., CHI L. Hemadsorption (adsorption-hemagglutination) test for viral agents in tissue culture with special reference to influenza. Proc Soc Exp Biol Med. 1958 Apr;97(4):802–809. doi: 10.3181/00379727-97-23884. [DOI] [PubMed] [Google Scholar]
  18. Six H. R., Kasel J. A. Radioimmunoprecipitation assay for quantitation of serum antibody to the hemagglutinin of type A influenza virus. J Clin Microbiol. 1978 Feb;7(2):165–171. doi: 10.1128/jcm.7.2.165-171.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Underdown B. J., De Rose J., Plaut A. Disulfide bonding of secretory component to a single monomer subunit in human secretory IgA. J Immunol. 1977 May;118(5):1816–1821. [PubMed] [Google Scholar]
  20. Waldman R. H., Mann J. J., Kasel J. A. Influenza virus neutralizing antibody in human respiratory secretions. J Immunol. 1968 Jan;100(1):80–85. [PubMed] [Google Scholar]
  21. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  22. Webster R. G., Kasel J. A., Couch R. B., Laver W. G. Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans. J Infect Dis. 1976 Jul;134(1):48–58. doi: 10.1093/infdis/134.1.48. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES